Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuitive Surgical
ISRG
|
+$828M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$788M |
| 3 |
Qualcomm
QCOM
|
+$771M |
| 4 |
Apple
AAPL
|
+$719M |
| 5 |
Baxter International
BAX
|
+$571M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.57B |
| 2 |
Wells Fargo
WFC
|
+$967M |
| 3 |
KKR & Co
KKR
|
+$455M |
| 4 |
Booking.com
BKNG
|
+$401M |
| 5 |
GGP
GGP Inc.
GGP
|
+$384M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 29.32% |
| 2 | Technology | 13.38% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 9.31% |
| 5 | Consumer Discretionary | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6501
ProShares Ultra Bloomberg Natural Gas
BOIL
$302M
| – | – |
0
| – | -$15K |
2018 Q2
1 quarter
|
|
6502
Bank Of The James
BOTJ
$122M
| – | – |
-289
| Closed | -$4K | – |
|
6503
Bridgford Foods
BRID
$50.7M
| $0 | ﹤0.01% |
1
| – | – |
2017 Q4
3 quarters
|
|
6504
Broadway Financial
BYFC
$105M
| $0 | ﹤0.01% |
54
| – | – |
2013 Q4
19 quarters
|
|
6505
Cenntro
CENN
$7.44M
| – | – |
0
| – | – |
2018 Q2
1 quarter
|
|
6506
Cemtrex
CETX
$2.96M
| – | – |
0
| – | – |
2015 Q2
13 quarters
|
|
6507
Comstock Holding Companies
CHCI
$173M
| $0 | ﹤0.01% |
77
-608
| -89% | -$1.65K |
2018 Q2
1 quarter
|
|
6508
Co-Diagnostics
CODX
$4.57M
| – | – |
-9
| Closed | -$1K | – |
|
6509
Cohen & Co
COHN
$32.9M
| $0 | ﹤0.01% |
5
| – | – |
2017 Q4
3 quarters
|
|
6510
Canterbury Park Holding Corp
CPHC
$82M
| $0 | ﹤0.01% |
26
| – | – |
2017 Q4
3 quarters
|
|
6511
Cardiff Oncology
CRDF
$70.1M
| $0 | ﹤0.01% |
63
+7
| +13% | +$33 |
2013 Q3
20 quarters
|
|
6512
CSP Inc
CSPI
$77.6M
| – | – |
-2,932
| Closed | -$14K | – |
|
6513
Citius Pharmaceuticals
CTXR
$12.6M
| $0 | ﹤0.01% |
2
+1
| +100% | +$48 |
2018 Q2
1 quarter
|
|
6514
Bio Green Med Solution Inc
BGMS
$6.02M
| – | – |
0
| – | – |
2013 Q2
21 quarters
|
|
6515
Dare Bioscience
DARE
$14.3M
| $0 | ﹤0.01% |
5
| – | – |
2015 Q1
14 quarters
|
|
6516
Donegal Group Class B
DGICB
$709M
| $0 | ﹤0.01% |
1
| – | – |
2017 Q4
3 quarters
|
|
6517
Edesa Biotech
EDSA
$24.8M
| – | – |
0
| – | – |
2017 Q1
6 quarters
|
|
6518
DELISTED
Electro-Sensors
ELSE
| – | – |
-2
| Closed | – | – |
|
6519
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.32M
| – | – |
-180
| Closed | -$10K | – |
|
6520
Enveric Biosciences
ENVB
$6.18M
| – | – |
0
| – | – |
2017 Q4
3 quarters
|
|
6521
Eterna Therapeutics
ERNA
$2.44M
| – | – |
0
| – | – |
2013 Q4
19 quarters
|
|
6522
Vanguard ESG US Stock ETF
ESGV
$13.3B
| $0 | ﹤0.01% |
+1
| New | +$50 |
2018 Q3
0 quarters
|
|
6523
iShares Fallen Angels USD Bond ETF
FALN
$1.58B
| – | – |
-10,722
| Closed | -$282K | – |
|
6524
iShares Systematic Bond ETF
SYSB
$1.3B
| – | – |
-113
| Closed | -$11K | – |
|
6525
DELISTED
FlexShopper
FPAY
| $0 | ﹤0.01% |
9
-4
| -31% | -$12 |
2017 Q3
4 quarters
|
|
Similar funds
Morgan Stanley's Q3 2018 Portfolio in Review
As of Q3 2018, Morgan Stanley held 7,051 positions worth $400B, up 7.9% from $370B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Morgan Stanley's Q3 2018 filing shows 207 new, 2,867 increased, 3,205 reduced and 166 closed positions. Its largest new stake was Elanco Animal Health: 9,012,591 shares worth $314M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.57B.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q3 2018 buy was Elanco Animal Health: 9,012,591 shares worth $314M.
- Morgan Stanley added most to Intuitive Surgical in Q3 2018, an estimated $828M increase.
- Morgan Stanley's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.57B.
- Morgan Stanley fully exited GGP Inc. in Q3 2018, selling an estimated $384M.
- Morgan Stanley's ten largest holdings make up 15% of its $400B portfolio in Q3 2018.
- Morgan Stanley opened 207 new positions and closed 166 in Q3 2018.
- Morgan Stanley's portfolio value rose 7.9% quarter-over-quarter to $400B.
Based on Morgan Stanley's 13F filing for Q3 2018, filed 14 Nov 2018.